Cargando…

Heme Deficiency in Alzheimer's Disease: A Possible Connection to Porphyria

Mechanisms that cause Alzheimer's disease (AD), an invariably fatal neurodegenerative disease, are unknown. Important recent data indicate that neuronal heme deficiency may contribute to AD pathogenesis. If true, factors that contribute to the intracellular heme deficiency could potentially alt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dwyer, Barney E., Stone, Meghan L., Zhu, Xiongwei, Perry, George, Smith, Mark A.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559910/ https://www.ncbi.nlm.nih.gov/pubmed/17047301 http://dx.doi.org/10.1155/JBB/2006/24038

Ejemplares similares

Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit?
por: Petrides, Petro E., et al.
Publicado: (2021)

Clinically Important Features of Porphyrin and Heme Metabolism and the Porphyrias
por: Besur, Siddesh, et al.
Publicado: (2014)

Prophylactic Heme Arginate Infusion for Acute Intermittent Porphyria
por: Kuo, Hung-Chou, et al.
Publicado: (2021)

Benefits of prophylactic heme therapy in severe acute intermittent porphyria
por: Yarra, Pradeep, et al.
Publicado: (2019)

Iron, Heme Synthesis and Erythropoietic Porphyrias: A Complex Interplay
por: Poli, Antoine, et al.
Publicado: (2021)

Acute Porphyria
por: Kernohan, R. J., et al.
Publicado: (1954)

Heme Deficiency Effects Offer Clue to Alzheimer Disease
por: Phelps, J
Publicado: (2003)

Alzheimer's Disease and Vascular Deficiency: Lessons from Imaging Studies and Down Syndrome
por: Reed-Cossairt, Arlene, et al.
Publicado: (2012)

Mitochondrial Drugs for Alzheimer Disease
por: Bonda, David J., et al.
Publicado: (2009)

Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches
por: Castellani, Rudy J., et al.
Publicado: (2009)

Phosphorylation of Tau Protein as the Link between Oxidative Stress, Mitochondrial Dysfunction, and Connectivity Failure: Implications for Alzheimer's Disease
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2013)

Porphyria and kidney diseases
por: Pallet, Nicolas, et al.
Publicado: (2018)

THE PORPHYRIAS
Publicado: (1981)

Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances
por: Wang, Wenzhang, et al.
Publicado: (2020)

Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease
por: Casadesus, Gemma, et al.
Publicado: (2007)

Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease
por: Bryan, Kathryn J, et al.
Publicado: (2008)

STUDIES IN PORPHYRIA : II. EVIDENCE FOR A DEFICIENCY OF STEROID Δ(4)-5α-REDUCTASE ACTIVITY IN ACUTE INTERMITTENT PORPHYRIA
por: Bradlow, H. Leon, et al.
Publicado: (1973)

Acute Intermittent Porphyria in a Man with Dual Enzyme Deficiencies
por: Cerbino, G. N., et al.
Publicado: (2020)

Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

Porphyria revisited.
por: Hurst, L C
Publicado: (1982)

Renal Failure Affects the Enzymatic Activities of the Three First Steps in Hepatic Heme Biosynthesis in the Acute Intermittent Porphyria Mouse
por: Unzu, Carmen, et al.
Publicado: (2012)

Liver Transplantation because of Acute Liver Failure due to Heme Arginate Overdose in a Patient with Acute Intermittent Porphyria
por: Frei, Pascal, et al.
Publicado: (2012)

Neurodegenerative Diseases: Mechanisms and Therapies
por: Smith, Mark A., et al.
Publicado: (2006)

BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease
por: Evans, Teresa A., et al.
Publicado: (2007)

Greater disease burden of variegate porphyria than hereditary coproporphyria: An Israeli nationwide study of neurocutaneous porphyrias
por: Kaftory, Ran, et al.
Publicado: (2021)

Infectious Mononucleosis and Porphyria
por: Dawson, T. A. J., et al.
Publicado: (1962)

Porphyria and hepatocellular carcinoma
por: Pierach, C.A.
Publicado: (1987)

Acute Hepatic Porphyria
por: Bissell, D. Montgomery, et al.
Publicado: (2015)

Acute intermittent porphyria
por: Syal, Kartik, et al.
Publicado: (2015)

Intermittent Acute Porphyria
por: Macleod, J. G., et al.
Publicado: (1953)

Porphyrias and Mental Handicap
por: Jancar, J.
Publicado: (1978)

An overview of the cutaneous porphyrias
por: Dawe, Robert
Publicado: (2017)

The Porphyrias: The Royal Purple?
por: Dean, Geoffrey
Publicado: (1970)

Laboratory Diagnosis of Porphyria
por: Di Pierro, Elena, et al.
Publicado: (2021)

Glycogen Synthase Kinase 3: A Point of Integration in Alzheimer's Disease and a Therapeutic Target?
por: Mondragón-Rodríguez, Siddhartha, et al.
Publicado: (2012)

Antimicrobial peptide β-defensin-1 expression is upregulated in Alzheimer’s brain
por: Williams, Wesley M, et al.
Publicado: (2013)

Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease: A Possible Connection
por: Wilkins, Heather M., et al.
Publicado: (2014)

Treatment advances in Alzheimer's disease based on the oxidative stress model
por: Friedlich, Avi L, et al.
Publicado: (2009)

Heme Oxygenase-1 Deficiency
por: Renji, Soumya, et al.
Publicado: (2021)

Posttranslational modifications of α-tubulin in alzheimer disease
por: Zhang, Fan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l5qm1efihkqq0ft7urtkjrdk5g